HCA Healthcare (NYSE:HCA) Rating Increased to Buy at Goldman Sachs Group

Goldman Sachs Group upgraded shares of HCA Healthcare (NYSE:HCA) from a neutral rating to a buy rating in a research report sent to investors on Wednesday morning, 24/7 WallStreet reports. The firm currently has $160.00 target price on the stock, up from their prior target price of $147.00.

Other equities research analysts have also recently issued reports about the company. Zacks Investment Research upgraded GALP ENERGIA SG/ADR from a sell rating to a hold rating in a research note on Monday, May 27th. Barclays set a $24.00 target price on Tenet Healthcare and gave the stock a hold rating in a research note on Wednesday, April 17th. UBS Group restated a sell rating on shares of in a research note on Monday, June 24th. Raymond James set a $86.00 price target on Gilead Sciences and gave the company a buy rating in a research note on Tuesday, April 23rd. Finally, Jefferies Financial Group set a $158.00 price target on HCA Healthcare and gave the company a buy rating in a research note on Wednesday, April 17th. Two analysts have rated the stock with a sell rating, three have issued a hold rating and nineteen have issued a buy rating to the stock. HCA Healthcare presently has an average rating of Buy and a consensus price target of $149.87.

NYSE HCA opened at $141.51 on Wednesday. The business’s fifty day simple moving average is $129.96. HCA Healthcare has a fifty-two week low of $105.28 and a fifty-two week high of $147.42. The company has a market capitalization of $47.46 billion, a PE ratio of 14.48, a PEG ratio of 1.11 and a beta of 0.80.

HCA Healthcare (NYSE:HCA) last released its earnings results on Tuesday, April 30th. The company reported $2.97 earnings per share for the quarter, topping the consensus estimate of $2.31 by $0.66. HCA Healthcare had a negative return on equity of 112.65% and a net margin of 7.71%. The firm had revenue of $12.52 billion during the quarter, compared to analysts’ expectations of $12.34 billion. During the same period in the prior year, the company earned $3.18 earnings per share. The company’s quarterly revenue was up 9.6% on a year-over-year basis. On average, research analysts predict that HCA Healthcare will post 10.4 earnings per share for the current year.

The company also recently declared a quarterly dividend, which was paid on Friday, June 28th. Stockholders of record on Monday, June 3rd were paid a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a dividend yield of 1.13%. The ex-dividend date of this dividend was Friday, May 31st. HCA Healthcare’s payout ratio is 16.38%.

In other news, insider Jon M. Foster sold 44,281 shares of the stock in a transaction on Friday, May 10th. The stock was sold at an average price of $122.28, for a total value of $5,414,680.68. Following the completion of the transaction, the insider now directly owns 96,052 shares in the company, valued at approximately $11,745,238.56. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 2.70% of the stock is currently owned by corporate insiders.

Hedge funds and other institutional investors have recently bought and sold shares of the stock. Diversified Trust Co grew its holdings in HCA Healthcare by 3.1% during the 2nd quarter. Diversified Trust Co now owns 14,860 shares of the company’s stock worth $2,009,000 after acquiring an additional 451 shares during the period. Xact Kapitalforvaltning AB grew its holdings in HCA Healthcare by 8.5% during the 2nd quarter. Xact Kapitalforvaltning AB now owns 54,499 shares of the company’s stock worth $7,367,000 after acquiring an additional 4,266 shares during the period. AMF Pensionsforsakring AB grew its holdings in HCA Healthcare by 6.6% during the 2nd quarter. AMF Pensionsforsakring AB now owns 209,081 shares of the company’s stock worth $28,261,000 after acquiring an additional 12,964 shares during the period. Zweig DiMenna Associates LLC acquired a new stake in HCA Healthcare during the 2nd quarter worth about $4,863,000. Finally, DNB Asset Management AS grew its holdings in HCA Healthcare by 27.0% during the 2nd quarter. DNB Asset Management AS now owns 51,350 shares of the company’s stock worth $6,941,000 after acquiring an additional 10,907 shares during the period. Institutional investors and hedge funds own 70.23% of the company’s stock.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.

Recommended Story: What does a bar chart display?

Analyst Recommendations for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.